Syndromes that predispose to epistaxis.


Journal

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 01 10 2018
accepted: 19 01 2019
pubmed: 1 2 2019
medline: 31 5 2019
entrez: 1 2 2019
Statut: ppublish

Résumé

Our aim was to evaluate if epistaxis is directly associated with the etiology or pathophysiological mechanism which results in the syndrome itself or arises as a secondary effect. We performed an extensive literature review of the web-based PubMed database from the National Library of Medicine to ascertain syndromes related to this condition. Etiology, pathophysiological mechanisms, occurrence, clinical features and management were noted for each of these syndromes. Epistaxis is commonly seen in syndromes that are usually directly related to vascular abnormalities or coagulation defects. However, in some cases, it is not. Since a number of these syndromes are rare and elaborate tests are not carried out in the absence of a positive family history or until other specific clinical features appear, a risk of underdiagnosis and the dilemma of whether epistaxis is specifically related to the syndrome or a secondary effect still remains.

Identifiants

pubmed: 30701275
doi: 10.1007/s00405-019-05310-1
pii: 10.1007/s00405-019-05310-1
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

939-944

Références

Yau S (2015) An update on epistaxis. Aust Fam Physician 44(9):653–656
pubmed: 26488045
Tomkinson A, Roblin DG, Flanagan P (1997) et al Patterns of hospitál attendance with epistaxis. Rhinology 35:129–131
pubmed: 9403944
Nikoyan L, Matthews S (2012) Epistaxis and hemostatic devices. Oral MaxillofacSurg Clin North Am 24:219–228
doi: 10.1016/j.coms.2012.01.009
Scholler R (2009) Epistaxis. N Engl J Med 360:784–789
doi: 10.1056/NEJMcp0807078
McClurg SW, Carrau R (2014) Endoscopic management of posterior epistaxis: a review. ACTA Otorhinolaryngol Ital 34:1–8
pubmed: 24711676 pmcid: 3970224
Melia L, McGarry G (2011) Epistaxis: update on management. Curr Opin Otolaryngol Head Neck Surg 19:30–35
doi: 10.1097/MOO.0b013e328341e1e9 pubmed: 21150620
Cummings CW (2005) Cummings otolaryngology head and neck surgery, 4 ed. Elsevier Mosby, Philadelphia
Fatakia A, Winters R, Amedee RG (2010) Epistaxis: a common problem. Ochsner J 10(3):176–178
pubmed: 21603374 pmcid: 3096213
Ross P, McClymont L (2006) Epistaxis. Surg (Oxf) 24:296–298
doi: 10.1053/j.mpsur.2006.07.005
Chin CJ, Rotenberg BW, Witterick IJ (2016) Epistaxis in hereditary hemorrhagic telangiectasia: an evidence based review of surgical management. J Otolaryngol Head Neck Surg 45:3
doi: 10.1186/s40463-016-0116-8 pubmed: 26754744 pmcid: 4709944
D’Andrea G, Chetta M, Margaglione M (2009) Inherited platelet disorders: thrombocytopenias and thrombocytopathies. Blood Transfus 7(4):278–292
pubmed: 20011639 pmcid: 2782805
Hasanzad M (2014) Bernard–Soulier syndrome (BSS) & tuberculosis: a case report. Int J Mycobacteriol 3:283–285
doi: 10.1016/j.ijmyco.2014.10.006 pubmed: 26786628
Lanza F (2006) Bernard-Soulier syndrome (Hemorrhagiparousthrombocytic dystrophy). Orphanet J Rare Dis 1:46
doi: 10.1186/1750-1172-1-46 pubmed: 17109744 pmcid: 1660532
Jin X-L, Wang Z-H, Xiao X-B, Huang L-S, Zhao X-Y (2014) Blue rubber bleb nevus syndrome: a case report and literature review. World J Gastroenterol 20(45):17254–17259
doi: 10.3748/wjg.v20.i45.17254 pubmed: 25493043 pmcid: 4258599
Blue rubber nevus syndrome in orphanet (2017) https://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=415&Disease_Disease_Search_diseaseGroup=Blue-rubber-bleb-nevus&Disease_Disease_Search_diseaseType=Pat&Disease(s)/group%20of%20diseases=Blue-rubber-bleb-nevus&title=Blue-rubber-bleb-nevus&search=Disease_Search_Simple . Accessed 21 Sept 2018
Brambila-Tapia A, García-Ortiz J, Brouillard P, Nguyen HL, Vikkula M et al (2017) GATA2 null mutation associated with incomplete penetrance in a family with Emberger syndrome. Hematology 8:467–471
Michelini S, Cardone M, Agga MHO, Bruson A, Maltese PE et al (2016) A rare case of emberger syndrome caused by a de novo mutation in the GATA2 gene. Lymphology 49:15–20
pubmed: 29906059
Michael R, Meera C, Derek L, Syana S, Madhvi R et al (2017) Epistaxis as a common presenting symptom of Glanzmann’s thrombasthenia, a rare qualitative platelet disorder: illustrative case examples. Hindawi Case Rep Emerg Med 2017:1–6
Nurden AT (2006) Glanzmann thrombasthenia. Orphanet J Rare Dis 1:10
doi: 10.1186/1750-1172-1-10 pubmed: 16722529 pmcid: 1475837
Posadas MD, Viejo Stuart S, Romano O, Giamello A (2014) Gorham-Stoutsyndrome: a case report. Eur Rev Med Pharmacol Sci 18(1 Suppl):81–83
pubmed: 24825048
Nikolaou VS, Chytas D, Korres D, Efstathopoulos N (2014) Vanishing bone disease (Gorham-Stout syndrome): a review of a rare entity. World J Orthop 5(5):694–698
doi: 10.5312/wjo.v5.i5.694 pubmed: 4133478 pmcid: 4133478
Gunay-Aygun M, Zivony-Elboum Y, Gumruk F, Geiger D, Cetin M et al (2010) Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3p. Blood 116(23):4990–5001
doi: 10.1182/blood-2010-05-286534 pubmed: 20709904 pmcid: 3012593
Huizing M, Malicdan MCV, Gochuico BR, Gahl WA (2017) Hermansky-Pudlak syndrome. GeneReviews® [Internet] https://www.ncbi.nlm.nih.gov/books/NBK1287 . Accessed 21 Sept 2018
Pate GE, Chandavimol M, Naiman SC, Webb JG (2004) Heyde’s syndrome: a review. J Heart Valve Dis 13(5):701–712
pubmed: 15473466
Savoia A, Pecci A (2015) MYH9-related disorders GeneReviews® [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK2689/ Accessed 21 Sept 2018
Althaus K, Greinacher A (2009) MYH9-related platelet disorders. Semin Thromb Hemost 35(2):189–203
doi: 10.1055/s-0029-1220327 pubmed: 19408192
Antic DA, Vukovic VM, Milosevic Feenstra JD, Kralovics R, Bogdanovic AD et al (2016) 8p11 myeloproliferative syndrome: diagnostic challenges and pitfalls. J BUON21 21(3):745–749
Allanson JE, Roberts AE, Noonan Syndrome (2016) GeneReviews® [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK1124/ . Accessed 21 Sept 2018
Giacobbe V, Rossetti D, Vitale SG, Rapisarda AM, Padula M et al (2016) Otorrhagia and nosebleed as first signs of intravascular absorption syndrome during hysteroscopy: from bench to bedside. Kathmandu Univ Med J (KUMJ) 14(53):87–89
Cação G, Correia FD, Pereira-Monteiro J (2016) SUNCT syndrome: a cohort of 15 Portuguese patients. Cephalalgia 36(10):1002–1006
doi: 10.1177/0333102415620252 pubmed: 26611683
Buchbinder D, Nugent DJ, Fillipovich AH (2014) Wiskott–Aldrich syndrome: diagnosis, current management, and emerging treatments. Appl Clin Genet 7:55–66
doi: 10.2147/TACG.S58444 pubmed: 24817816 pmcid: 4012343
Silva BM, Hosman AE, Devlin HL, Shovlin CL (2013) Lifestyle and dietary influences on nosebleed severity in hereditary hemorrhagic telangiectasia. Laryngoscope 123(5):1092–1099
doi: 10.1002/lary.23893 pubmed: 23404156
Garg N, Khunger M, Gupta A, Kumar N (2014) Optimal management of hereditary hemorrhagic telangiectasia. J Blood Med 5:191–206
pubmed: 25342923 pmcid: 4206399
Kim JY, Chae M, Lee J (2013) Operative hysteroscopy intravascular absorption syndrome caused by massive absorption of 0.9% saline as the distention/irrigation medium. Korean J Anesthesiol 65(6 Suppl):S44–S46
doi: 10.4097/kjae.2013.65.6S.S44 pubmed: 24478868 pmcid: 3903856
Fiorella ML, Ross D, Henderson KJ, White RI (2005) Outcome of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia. Laryngoscope 115(2):301–305
doi: 10.1097/01.mlg.0000154754.39797.43 pubmed: 15689755
Lund VJ, Howard DJ (1997) Closure of the nasal cavities in the treatment of refractory hereditary haemorrhagic telangiectasia. J Laryngol Otol 111(1):30–33
doi: 10.1017/S0022215100136369 pubmed: 9292127
Faughnan ME, Palda VA, Garcia-Tsao G, Geisthoff UW, McDonald J et al (2011) International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet 48(2):73–87
doi: 10.1136/jmg.2009.069013 pubmed: 19553198

Auteurs

Anasuya Guha (A)

Department of Otorhinolaryngology, 3rd Faculty of Medicine and University Hospital Kralovske Vinohrady, Charles University, Srobarova 1150/50, 10034, Prague, Czech Republic. anasuya.guha@fnkv.cz.

Petr Schalek (P)

Department of Otorhinolaryngology, 3rd Faculty of Medicine and University Hospital Kralovske Vinohrady, Charles University, Srobarova 1150/50, 10034, Prague, Czech Republic.

Martin Chovanec (M)

Department of Otorhinolaryngology, 3rd Faculty of Medicine and University Hospital Kralovske Vinohrady, Charles University, Srobarova 1150/50, 10034, Prague, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH